BioCentury | Feb 8, 2019
Company News

Management tracks: Takeda’s Plump becomes president of R&D

...franchise head of ophthalmology. Guerard succeeds Jerry Cagle, a board member, who was acting CEO. CavoGene LifeSciences...
Items per page:
1 - 1 of 1
BioCentury | Feb 8, 2019
Company News

Management tracks: Takeda’s Plump becomes president of R&D

...franchise head of ophthalmology. Guerard succeeds Jerry Cagle, a board member, who was acting CEO. CavoGene LifeSciences...
Items per page:
1 - 1 of 1